•	In 1982, the FDA approved breast thermography as an adjunctive diagnostic breast cancer screening procedure.
•	Over 800 peer-reviewed studies on breast thermography exist in the index-medicus literature.
•	Well over 300,000 women have been included as study participants, and some of these studies have followed patients up to 12 years.
•	Breast infrared imaging has an average sensitivity and specificity of 90%.
•	An abnormal infrared image is 10 times more significant as a future risk indicator for breast cancer than a first order family history.
•	An abnormal infrared image is the single most important marker of high risk for developing breast cancer.
•	Breast thermography has the ability to detect the first signs that a cancer may be forming - up to 10 years before any other procedure can detect it.
•	When used as part of a multimodal approach (clinical examination + mammography + thermography), 95% of early stage cancers may be detected.